Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms

Kevin D. Mlynek, Mary T. Callahan, Anton V. Shimkevitch, Jackson T. Farmer, Jennifer L. Endres, Mélodie Marchand, Kenneth W Bayles, Alexander R. Horswill, Jeffrey B. Kaplan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Previous studies showed that sub-MIC levels of β-lactam antibiotics stimulate biofilm formation in most methicillin-resistant Staphylococcus aureus (MRSA) strains. Here, we investigated this process by measuring the effects of sub-MIC amoxicillin on biofilm formation by the epidemic community-associated MRSA strain USA300. We found that sub-MIC amoxicillin increased the ability of USA300 cells to attach to surfaces and form biofilms under both static and flow conditions. We also found that USA300 biofilms cultured in sub-MIC amoxicillin were thicker, contained more pillar and channel structures, and were less porous than biofilms cultured without antibiotic. Biofilm formation in sub-MIC amoxicillin correlated with the production of extracellular DNA (eDNA). However, eDNA released by amoxicillin-induced cell lysis alone was evidently not sufficient to stimulate biofilm. Sub-MIC levels of two other cell wall-active agents with different mechanisms of action - D-cycloserine and fosfomycin - also stimulated eDNA-dependent biofilm, suggesting that biofilm formation may be a mechanistic adaptation to cell wall stress. Screening a USA300 mariner transposon library for mutants deficient in biofilm formation in sub-MIC amoxicillin identified numerous known mediators of S. aureus β-lactam resistance and biofilm formation, as well as novel genes not previously associated with these phenotypes. Our results link cell wall stress and biofilm formation in MRSA and suggest that eDNA-dependent biofilm formation by strain USA300 in low-dose amoxicillin is an inducible phenotype that can be used to identify novel genes impacting MRSA β-lactam resistance and biofilm formation.

Original languageEnglish (US)
Pages (from-to)2639-2651
Number of pages13
JournalAntimicrobial Agents and Chemotherapy
Volume60
Issue number5
DOIs
StatePublished - May 2016

Fingerprint

Amoxicillin
Biofilms
Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus
Lactams
Cell Wall
DNA
Cycloserine
Anti-Bacterial Agents
Fosfomycin
Phenotype
Genes
Libraries

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Mlynek, K. D., Callahan, M. T., Shimkevitch, A. V., Farmer, J. T., Endres, J. L., Marchand, M., ... Kaplan, J. B. (2016). Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms. Antimicrobial Agents and Chemotherapy, 60(5), 2639-2651. https://doi.org/10.1128/AAC.02070-15

Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms. / Mlynek, Kevin D.; Callahan, Mary T.; Shimkevitch, Anton V.; Farmer, Jackson T.; Endres, Jennifer L.; Marchand, Mélodie; Bayles, Kenneth W; Horswill, Alexander R.; Kaplan, Jeffrey B.

In: Antimicrobial Agents and Chemotherapy, Vol. 60, No. 5, 05.2016, p. 2639-2651.

Research output: Contribution to journalArticle

Mlynek, KD, Callahan, MT, Shimkevitch, AV, Farmer, JT, Endres, JL, Marchand, M, Bayles, KW, Horswill, AR & Kaplan, JB 2016, 'Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms', Antimicrobial Agents and Chemotherapy, vol. 60, no. 5, pp. 2639-2651. https://doi.org/10.1128/AAC.02070-15
Mlynek KD, Callahan MT, Shimkevitch AV, Farmer JT, Endres JL, Marchand M et al. Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms. Antimicrobial Agents and Chemotherapy. 2016 May;60(5):2639-2651. https://doi.org/10.1128/AAC.02070-15
Mlynek, Kevin D. ; Callahan, Mary T. ; Shimkevitch, Anton V. ; Farmer, Jackson T. ; Endres, Jennifer L. ; Marchand, Mélodie ; Bayles, Kenneth W ; Horswill, Alexander R. ; Kaplan, Jeffrey B. / Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms. In: Antimicrobial Agents and Chemotherapy. 2016 ; Vol. 60, No. 5. pp. 2639-2651.
@article{3cf6b9bcd1b34bcf83e32f14982034e6,
title = "Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms",
abstract = "Previous studies showed that sub-MIC levels of β-lactam antibiotics stimulate biofilm formation in most methicillin-resistant Staphylococcus aureus (MRSA) strains. Here, we investigated this process by measuring the effects of sub-MIC amoxicillin on biofilm formation by the epidemic community-associated MRSA strain USA300. We found that sub-MIC amoxicillin increased the ability of USA300 cells to attach to surfaces and form biofilms under both static and flow conditions. We also found that USA300 biofilms cultured in sub-MIC amoxicillin were thicker, contained more pillar and channel structures, and were less porous than biofilms cultured without antibiotic. Biofilm formation in sub-MIC amoxicillin correlated with the production of extracellular DNA (eDNA). However, eDNA released by amoxicillin-induced cell lysis alone was evidently not sufficient to stimulate biofilm. Sub-MIC levels of two other cell wall-active agents with different mechanisms of action - D-cycloserine and fosfomycin - also stimulated eDNA-dependent biofilm, suggesting that biofilm formation may be a mechanistic adaptation to cell wall stress. Screening a USA300 mariner transposon library for mutants deficient in biofilm formation in sub-MIC amoxicillin identified numerous known mediators of S. aureus β-lactam resistance and biofilm formation, as well as novel genes not previously associated with these phenotypes. Our results link cell wall stress and biofilm formation in MRSA and suggest that eDNA-dependent biofilm formation by strain USA300 in low-dose amoxicillin is an inducible phenotype that can be used to identify novel genes impacting MRSA β-lactam resistance and biofilm formation.",
author = "Mlynek, {Kevin D.} and Callahan, {Mary T.} and Shimkevitch, {Anton V.} and Farmer, {Jackson T.} and Endres, {Jennifer L.} and M{\'e}lodie Marchand and Bayles, {Kenneth W} and Horswill, {Alexander R.} and Kaplan, {Jeffrey B.}",
year = "2016",
month = "5",
doi = "10.1128/AAC.02070-15",
language = "English (US)",
volume = "60",
pages = "2639--2651",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Effects of low-dose amoxicillin on Staphylococcus aureus USA300 biofilms

AU - Mlynek, Kevin D.

AU - Callahan, Mary T.

AU - Shimkevitch, Anton V.

AU - Farmer, Jackson T.

AU - Endres, Jennifer L.

AU - Marchand, Mélodie

AU - Bayles, Kenneth W

AU - Horswill, Alexander R.

AU - Kaplan, Jeffrey B.

PY - 2016/5

Y1 - 2016/5

N2 - Previous studies showed that sub-MIC levels of β-lactam antibiotics stimulate biofilm formation in most methicillin-resistant Staphylococcus aureus (MRSA) strains. Here, we investigated this process by measuring the effects of sub-MIC amoxicillin on biofilm formation by the epidemic community-associated MRSA strain USA300. We found that sub-MIC amoxicillin increased the ability of USA300 cells to attach to surfaces and form biofilms under both static and flow conditions. We also found that USA300 biofilms cultured in sub-MIC amoxicillin were thicker, contained more pillar and channel structures, and were less porous than biofilms cultured without antibiotic. Biofilm formation in sub-MIC amoxicillin correlated with the production of extracellular DNA (eDNA). However, eDNA released by amoxicillin-induced cell lysis alone was evidently not sufficient to stimulate biofilm. Sub-MIC levels of two other cell wall-active agents with different mechanisms of action - D-cycloserine and fosfomycin - also stimulated eDNA-dependent biofilm, suggesting that biofilm formation may be a mechanistic adaptation to cell wall stress. Screening a USA300 mariner transposon library for mutants deficient in biofilm formation in sub-MIC amoxicillin identified numerous known mediators of S. aureus β-lactam resistance and biofilm formation, as well as novel genes not previously associated with these phenotypes. Our results link cell wall stress and biofilm formation in MRSA and suggest that eDNA-dependent biofilm formation by strain USA300 in low-dose amoxicillin is an inducible phenotype that can be used to identify novel genes impacting MRSA β-lactam resistance and biofilm formation.

AB - Previous studies showed that sub-MIC levels of β-lactam antibiotics stimulate biofilm formation in most methicillin-resistant Staphylococcus aureus (MRSA) strains. Here, we investigated this process by measuring the effects of sub-MIC amoxicillin on biofilm formation by the epidemic community-associated MRSA strain USA300. We found that sub-MIC amoxicillin increased the ability of USA300 cells to attach to surfaces and form biofilms under both static and flow conditions. We also found that USA300 biofilms cultured in sub-MIC amoxicillin were thicker, contained more pillar and channel structures, and were less porous than biofilms cultured without antibiotic. Biofilm formation in sub-MIC amoxicillin correlated with the production of extracellular DNA (eDNA). However, eDNA released by amoxicillin-induced cell lysis alone was evidently not sufficient to stimulate biofilm. Sub-MIC levels of two other cell wall-active agents with different mechanisms of action - D-cycloserine and fosfomycin - also stimulated eDNA-dependent biofilm, suggesting that biofilm formation may be a mechanistic adaptation to cell wall stress. Screening a USA300 mariner transposon library for mutants deficient in biofilm formation in sub-MIC amoxicillin identified numerous known mediators of S. aureus β-lactam resistance and biofilm formation, as well as novel genes not previously associated with these phenotypes. Our results link cell wall stress and biofilm formation in MRSA and suggest that eDNA-dependent biofilm formation by strain USA300 in low-dose amoxicillin is an inducible phenotype that can be used to identify novel genes impacting MRSA β-lactam resistance and biofilm formation.

UR - http://www.scopus.com/inward/record.url?scp=84964956152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964956152&partnerID=8YFLogxK

U2 - 10.1128/AAC.02070-15

DO - 10.1128/AAC.02070-15

M3 - Article

C2 - 26856828

AN - SCOPUS:84964956152

VL - 60

SP - 2639

EP - 2651

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -